Fortress Biotech, Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Fortress Biotech, Inc. (FBIO) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2018-03-16
- Fortress Biotech, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2017-12-31 was $0.00.
- Fortress Biotech, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2017-09-30 was -$42.00K, a 103.71% decline year-over-year.
- Fortress Biotech, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2016-12-31 was $0.00.
- Fortress Biotech, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2016-09-30 was $1.13M.
- Fortress Biotech, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Fortress Biotech, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2016 was $1.13M.
- Fortress Biotech, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2015 was $0.00.
- Fortress Biotech, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2014 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month as first filed | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$42.00K derived: sum of 2 quarters · filed 2018-03-16 | $0.00 10-K · filed 2018-03-16 | |||
| 2017-09-30 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | ||||
| 2017-06-30 | $42.00K 10-Q · filed 2017-08-09 | |||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $1.13M derived: sum of 2 quarters · filed 2018-03-16 | $1.13M 10-K · filed 2018-03-16 | -$1.13M 10-K · filed 2017-03-16 | ||
| 2016-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.13M 10-Q · filed 2017-11-09 | -$1.13M 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | |||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | |||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |